RealMed enjoys a nearly 99-percent renewal rate among its current customers and attracted 4,000 new doctors
in 2009. Employment at the company is rising after a steady decline.
Legal complaint alleges new $20 million facility in Greenwood breaches partnership deal struck in 2001.
Indianapolis health care heavyweights are among those spending $635 million, employing 166 former aides to key congressional
leaders and committees in health reform process.
Eli Lilly and Co. has bought the rights to co-market a new cholesterol-fighting drug in the U.S., giving it a third heart drug for sales personnel
to push.
Another year of rapid change at Eli Lilly and Co. did little to move the company out from under the cloud cast by its best-selling
drug, Zyprexa.
Congress is on the cusp of transforming health insurance—if it can pass a health reform bill that was losing popularity
late in the year.
The decade witnessed a massive terrorist attack, two wars, and a building-and-buyout boom fueled by easy credit.
The Carmel-based life and health insurer immediately applied $161 million of the funds to its bank loans.
Exemption for not-for-profit health plans could saddle WellPoint with nearly $2 billion a year in new taxes.
By acquiring an experimental medicine for rheumatoid arthritis, the Indianapolis-based drugmaker is increasing its focus on autoimmune
diseases.
Landmark health care legislation backed by President Barack Obama passed its sternest Senate test in the pre-dawn hours early
Monday, overcoming Republican delaying tactics on a 60-40 vote that all but assures its passage by Christmas.
Hundreds of potential contractors turned out for informational meetings this week about construction work on a new Wishard Memorial Hospital.
Group presidents tell Indiana senators that the reform bill would expand dysfunctions of current health care systems.
Roche Diagnostics Corp., once the darling of the U.S. diabetes-device market, is now licking its wounds. And
it’s mulling whether to keep fighting on all fronts or to pull back.
Judge Sarah Evans Barker declared a Massachusetts woman in contempt of court for failing to remove her negative Internet
postings about an Indianapolis cosmetic surgeon.
More than half of the venture capital fund’s original investors took a pass on its $58 million successor, the newly launched
INext.
The U.S. Senate voted down a plan Tuesday to allow Americans to import prescriptions from abroad, handing drug makers
such as Indianapolis-based Eli Lilly and Co. a victory.
Indiana University, which has received nearly $600 million from the endowment over the last three decades, will leverage the
new gift to increase its
scientific discoveries and commercialize life science innovations.
Once-a-month injection of best-selling drug will have patents that could extend until 2018.
Carmel firm using $12 million in venture capital for buying spree is now nation’s second-largest operator of sleep centers.
